BioCentury
ARTICLE | Clinical News

CER006: Phase I data

August 1, 2011 7:00 AM UTC

In a 4-arm Phase I trial, CER006 was safe and well tolerated. The company also said the study "suggests fast and improved delivery" of ibuprofen with CER006 compared with an undisclosed marketed compa...